on Biotest AG (isin : DE0005227201)
Change in the Chief Financial Officer at Biotest AG
Biotest AG has announced a change in its Chief Financial Officer. Ms. Ainhoa Mendizabal Zubiaga is stepping down for personal reasons. The company expressed gratitude for her efforts and wished her success in the future.
Mr. Martin Möller will take over as Interim Chief Financial Officer for the next six months, starting September 14, 2024. The company highlights Mr. Möller's experience and looks forward to his leadership during this transition period.
Biotest AG remains confident in its future as it navigates this change. The leadership transition is seen as a step towards continued stability and growth.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Biotest AG news